Japanese Journal of Clinical Oncology 30:301-305 (2000)
© 2000 Foundation for Promotion of Cancer Research
Characterization of Intracellular Cytokine Profile of CD4(+) T Cells in Peripheral Blood and Tumor-draining Lymph Nodes of Patients with Gastrointestinal Cancer
1Department of Surgery, Division of Surgical Oncology, The University of Tokyo and 2Cancer Institute Hospital, Tokyo, Japan
Background: Analysis of serum cytokine levels has shown that cancer-bearing hosts have lower levels of IL-2 and IFN-
, suggesting that Th1-type immunity is impaired by cancer. However, the mechanisms of the Th1 dysfunction are not clearly understood.
Method: The frequencies of Th1 cells in CD4(+) helper T cells were evaluated with an intracytoplasmic cytokine staining method in peripheral blood lymphocytes (PBL) and lymph node lymphocytes (LNL) of patients with gastrointestinal cancer.
Results: Activation of lymphocytes with PMA + Ionomycin induced the expression of IL-2 and IFN-
in each lymphocyte population. Compared with PBL of non-malignant donors, PBL in cancer patients contained significantly lower frequencies of CD4(+) T cells that produced IL-2 and IFN-
. LNL in cancer patients also contained lower levels of IL-2- and IFN-
-producing CD4(+) T cells, although the percentages did not show significant differences from those of PBL in the same patients.
Conclusion: Our data suggest that suppression of Th1 cytokine in cancer patients is,at least in part, due to the decreased frequency of Th1 cells with CD4(+) phenotype.
+ For reprints and all correspondence: Joji Kitayama, Department of Surgery, Division of Surgical Oncology, The University of Tokyo, Hongo 731, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: kitayama-1su@h.u-tokyo.ac.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.-N. Chen, J.-J. Lin, J. J. W. Chen, P.-H. Lee, C.-Y. Yang, M.-L. Kuo, K.-J. Chang, and F.-J. Hsieh Gene Expression Profile Predicts Patient Survival of Gastric Cancer After Surgical Resection J. Clin. Oncol., October 10, 2005; 23(29): 7286 - 7295. [Abstract] [Full Text] [PDF] |
||||
